Barts and The London School of Medicine and Dentistry
Clinical drug development is available for study to MSc or PGDip level, over a period of one year full-time or two- five years part time (variable mode).
We have developed a modular postgraduate programme in clinical drug development designed to give you the necessary academic background and specialist skills needed to carry out clinical drug development in a contract research organisation, pharmaceutical industry or health service environment.
If you are a nurse, medical doctor or other health professional working in contract research organisations, the pharmaceutical industry and healthcare, this programme has been designed for you.
The programme will:
- Allow you the option to study on a flexible part-time basis, or by distance learning.
- Give you an understanding of the regulatory framework underlying clinical research.
- Teach you to understand the principles of laboratory methodologies applied to clinical trials.
- Give you understanding of the steps involved in developing and implementing new drugs.
- Cover the key areas of expertise needed for a successful clinical research programme.
- Develop your skills and understanding in clinical microbiology, and will give you a thorough knowledge of associated subjects such as molecular biology.
Why study your MSc in Clinical drug development at Queen Mary?
Barts and the London School of Medicine and Dentistry is comprised of two world renowned teaching hospitals, St Bartholomew’s and The Royal London, which have made, and continue to make, an outstanding contribution to modern medicine. We are one of the top five in the UK for medicine in the 2008 Research Assessment Exercise.
MSc/PGDip in Clinical drug Development is based at The William Harvey Research Institute, the largest university-based pharmacological research institute in the UK. Our success in this area is illustrated by our publications in high-impact journals, accompanied by renewal and additional funding of one Medical Research Council and five Wellcome Programmes, which we lead or support as co-investigators. The Institute has strong links with the pharmaceutical industry both in the UK and abroad.
- Our location in the east of London and elsewhere in the East London Gateway will enhance your experience.
- Barts and The London is part of Queen Mary, the only university in central London to offer extensive campus-based facilities.
- We have modern state-of-the-art buildings alongside more traditional facilities such as our fantastic library.
- The modular nature of the programme is designed to fit in with your full-time employment.
For more information about intercalation please visit the Barts and The London School of Medicine and Dentistry website.
- Successfully completed at least 3 years of the MBBS, MbChB or equivalent medical course
- (for clinically based Masters this must include the equivalent of one year of patient based teaching (in hospital/GP practices/clinics)).
- Passed year 3 or 4 exams immediately prior to entry at the first opportunity.
- Demonstrate a clear and unequivocal interest in the field by written application +/- interview.
- For students internal and external to QMUL it is confirmed that the beginning of the first term for the following year starts after all the QMUL Masters assessments are completed.
Monday 4 February 2019